Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (1855)	1/19/1998 12:19:00 PM
From: poodle	Read Replies (1) \| Respond to of 7041

<<Zonagen is a fraud and a scam, and Joe Podolski is a crook.>> <<Shouldn't you be spending your time more constructively by sending letters to the SEC and FDA about Zonagen's fraudulent scheme? I have!>> Bill, may I ask you to explain how did Zonagen's executives benefit from the fraud? Have you Vasomax patent application (discussed by Asensio)? I am especially interested in ng/ml blood concentrations. Thank you.

To: Bill Wexler who wrote (1855)	1/19/1998 2:29:00 PM
From: Cosmo Daisey	Read Replies (2) \| Respond to of 7041

Bill, >>>>Shouldn't you be spending your time more constructively by sending letters to the SEC and FDA about Zonagen's fraudulent scheme? I have!>>>> Send a note to Business Week about the article written by Gene Marcial mentioning Zonagen as a competitor to Pfizer. I posted a note pointing out that even a meager attempt at dilligence would have revealed that their drug platform is an outdated generic drug that doesn't work and their is a lawsuit filed by former employees challenging the patent application. Turn up the heat on the hot shots that don't do any investigative work on the stocks they mention. Perhaps some BW people needed a bounce to get out of the stock and that is the reason for the mention in the article. Zonagen a competitor to Pfizer? ROTFLMAO Cosmo